Abstract
We report here that loss of the Sprouty2 gene (also known as Spry2) in mice resulted in enteric nerve hyperplasia, which led to esophageal achalasia and intestinal pseudo-obstruction. Glial cell line–derived neurotrophic factor (GDNF) induced hyperactivation of ERK and Akt in enteric nerve cells. Anti-GDNF antibody administration corrected nerve hyperplasia in Sprouty2-deficient mice. We show Sprouty2 to be a negative regulator of GDNF for the neonatal development or survival of enteric nerve cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kim, H.J. & Bar-Sagi, D. Nat. Rev. Mol. Cell Biol. 5, 441–450 (2004).
Wakioka, T. et al. Nature 412, 647–651 (2001).
Shim, K., Minowada, G., Coling, D.E. & Martin, G.R. Dev. Cell 8, 553–564 (2005).
Ieiri, S., Nishimura, J., Hirano, K., Suita, S. & Kanaide, H. Br. J. Pharmacol. 133, 529–538 (2001).
Barlow, A., de Graaff, E. & Pachnis, V. Neuron 40, 905–916 (2003).
Hofstra, R.M.W. et al. Nature 367, 375–376 (1994).
Santoro, M. et al. Science 267, 381–383 (1995).
Ghosh, P., Linder, J., Gallagher, T.F. & Quigley, E.M. Am. J. Gastroenterol. 89, 1880–1883 (1994).
Jing, S. et al. Cell 85, 1113–1124 (1996).
Basson, M.A. et al. Dev. Cell 8, 229–239 (2005).
Munakata, K., Morita, K., Okabe, I. & Sueoka, H. J. Pediatr. Surg. 20, 231–235 (1985).
Acknowledgements
We thank T. Yoshioka, M. Ohtsu, E. Fujimoto and N. Kinoshita for technical assistance, M. Takahashi (Nagoya University) for discussion and comments and Y. Nishi for manuscript preparation. This work was supported by special grants-in-aid from the Ministry of Education, Science, Technology, Sports and Culture of Japan; the Haraguchi Memorial Foundation; the Yamanouchi Foundation for Research on Metabolic Disorders; the Takeda Science Foundation; the Kato Memorial Foundation and the Uehara Memorial Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Fig. 1
Generation of Sprouty2-deficient mice. (PDF 1923 kb)
Supplementary Fig. 2
Body weight and intestinal pseudo-obstruction of Sprouty2-deficient mice. (PDF 3100 kb)
Supplementary Fig. 3
Contraction force of small intestine in response to CCh. (PDF 1313 kb)
Supplementary Fig. 4
ENS hyperplasia in Sprouty2-deficient mice. (PDF 1587 kb)
Supplementary Fig. 5
Immunoblotting for phosphorylation of Erk1/Erk2 and Akt in response to GDNF in neural and muscle layers of the colon. (PDF 110 kb)
Supplementary Fig. 6
Anti-GDNF–corrected ENS hyperplasia of Sprouty2-deficient mice. (PDF 6017 kb)
Supplementary Fig. 7
Chimeric Ret-Fc protein corrected ENS hyperplasia of Sprouty2-deficient mice. (PDF 6315 kb)
Rights and permissions
About this article
Cite this article
Taketomi, T., Yoshiga, D., Taniguchi, K. et al. Loss of mammalian Sprouty2 leads to enteric neuronal hyperplasia and esophageal achalasia. Nat Neurosci 8, 855–857 (2005). https://doi.org/10.1038/nn1485
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn1485
This article is cited by
-
KIF26A is mutated in the syndrome of congenital hydrocephalus with megacolon
Human Genetics (2023)
-
A novel mouse model of intestinal neuronal dysplasia: visualization of the enteric nervous system
Pediatric Surgery International (2023)
-
A dominant negative mutation uncovers cooperative control of caudal Wolffian duct development by Sprouty genes
Cellular and Molecular Life Sciences (2022)
-
Sprouty2—a Novel Therapeutic Target in the Nervous System?
Molecular Neurobiology (2019)
-
Sprouty4 interferes with cell proliferation and migration of breast cancer-derived cell lines
Tumor Biology (2014)